Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 1389-1394, May 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rumma, J.
Right arrow Articles by Cauchi, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rumma, J.
Right arrow Articles by Cauchi, M. N.

Effects of Graft-versus-Host Reaction on Inhibition of Tumor Growth in Vivo and on Tumor Cytotoxicity in Vitro1

Juri Rumma, David J. Davies2 and Maurice N. Cauchi

Department of Pathology and Immunology, Monash University Medical School, Melbourne, Victoria, 3181 Australia

In DA x Wistar F1 rats, growth of 104 Wistar-specific Sp 1 carcinoma cells s.c. was commonly prevented by a mild subclinical graft-versus-host reaction produced by injecting 50 x 106 Wistar spleen cells i.p. either concurrently with the tumor or 7 or 14 days previously. Spleen cells alone had no effect on established tumor, but their injection on Day 14 significantly reduced the recurrence rate after excision of tumor on Day 21. In vitro tests in tumor-bearing rats with graft-versus-host reactions showed increased spleen lymphocyte and serum cytotoxicity; these mechanisms may inhibit tumor growth in vivo. Because Wistar lymphocytes and Sp 1 cells are syngeneic, inhibition of tumor cannot be due to allograft rejection but is probably an effect of increased host immunoreactivity during the graft-versus-host reaction.

1 This work was supported by grants from the Anti-Cancer Council of Victoria.

2 To whom requests for reprints should be addressed, at The Department of Anatomical Pathology, St. Vincent's Hospital, Victoria Parade, Fitzroy, Victoria, 3065 Australia.

Received 9/ 3/76. Accepted 1/26/77.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.